MedTrace Logo

Feasibility of Home Monitoring of Visual Function in DR

NCT07386613 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2026-02-04

No results posted yet for this study

Summary

Diabetes is a serious condition where patients can develop complications in their body including their eyes which can lead to sight loss. Patients with diabetes are encouraged to attend yearly screening appointments at which signs of Diabetic Retinopathy (DR) are assessed. Attendance at these appointments and at any follow-up appointments can be time-consuming and inconvenient for those working. Better ways to monitor changes in vision are needed. Therefore, we are hoping to develop a set of eye tests that a person with diabetes can complete at home on a smartphone in collaboration with researchers at OKKO Health.

Conditions

  • Diabetes (DM)
  • Diabetes Complication
  • Diabetes (Insulin-requiring, Type 1 or Type 2)
  • Diabetic Retinopathy (DR)
  • Diabetes Pregnancy
  • Gestational Diabetes Mellitus in Pregnancy
  • Dialysis Patients

Interventions

DEVICE

Okko Health App

Okko Health digital health app used to assess visual acuity and contrast sensitivity using a mobile phone.

Sponsors & Collaborators

  • OKKO Health

    collaborator INDUSTRY

  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • Professor Ruth E Hogg, PhD · Queen's University, Belfast

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-09
Primary Completion
2024-06-20
Completion
2024-07-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07386613 on ClinicalTrials.gov